AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

VERTEX PHARMACEUTICALS INC / MA Director's Dealing 2020

Jun 5, 2020

29864_dirs_2020-06-05_d0351654-1df6-4a7c-b6c7-f2189593c0ce.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2020-06-03

Reporting Person: MCKENZIE DIANA (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	207	Indirect